Vistra Corp
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
VST$131.18-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| VISTRA CORP.CONSOLIDATED STATEMENTS OF CASH FLOWS(Millions of Dollars) | |||
|---|---|---|---|
| Year Ended December 31, | |||
| 2023 | 2022 | 2021 | |
| Cash flows — operating activities: | |||
| Net income (loss) | $1,492 | $(1,210) | $(1,264) |
| Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 1,956 | 2,047 | 2,050 |
| Deferred income tax expense (benefit), net | 457 | (359) | (475) |
| Gain on sale of land | (95) | (8) | (9) |
| Impairment of long-lived and other assets | 49 | 74 | 71 |
| Unrealized net (gain) loss from mark-to-market valuations of commodities | (490) | 2,510 | 759 |
| Unrealized net (gain) loss from mark-to-market valuations of interest rate swaps | 36 | (250) | (134) |
| Change in asset retirement obligation liability | 27 | 13 | (5) |
| Asset retirement obligation accretion expense | 34 | 34 | 38 |
| Impacts of Tax Receivable Agreement | 164 | 128 | (53) |
| Gain on TRA settlement | (29) | — | — |
| Bad debt expense | 164 | 179 | 110 |
| Stock-based compensation | 77 | 63 | 47 |
| Other, net | 103 | (71) | 50 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable — trade | 214 | (852) | (228) |
| Inventories | (174) | 36 | (100) |
| Accounts payable — trade | (350) | 94 | 402 |
| Commodity and other derivative contractual assets and liabilities | 82 | (228) | 32 |
| Margin deposits, net | 1,899 | (1,874) | (1,000) |
| Uplift securitization proceeds receivable from ERCOT | — | 544 | (544) |
| Accrued interest | 46 | 16 | 13 |
| Accrued taxes | 5 | (8) | (20) |
| Accrued employee incentive | 58 | 21 | (68) |
| Asset retirement obligation settlement | (81) | (87) | (88) |
| Major plant outage deferral | (32) | 20 | 2 |
| Other — net assets | 84 | (17) | (27) |
| Other — net liabilities | (243) | (330) | 235 |
| Cash provided by (used in) operating activities | 5,453 | 485 | (206) |
| Cash flows — investing activities: | |||
| Capital expenditures, including nuclear fuel purchases and LTSA prepayments | (1,676) | (1,301) | (1,033) |
| Proceeds from sales of nuclear decommissioning trust fund securities | 601 | 670 | 483 |
| Investments in nuclear decommissioning trust fund securities | (624) | (693) | (505) |
| Proceeds from sales of environmental allowances | 500 | 1,275 | 392 |
| Purchases of environmental allowances | (1,071) | (1,303) | (605) |
| Insurance proceeds | 15 | 39 | 89 |
| Proceeds from sales of property, plant and equipment | 115 | 78 | 30 |
| Other, net | (5) | (4) | (4) |
| Cash used in investing activities | (2,145) | (1,239) | (1,153) |
| VISTRA CORP.CONSOLIDATED STATEMENTS OF CASH FLOWS(Millions of Dollars) | |||
|---|---|---|---|
| Year Ended December 31, | |||
| 2023 | 2022 | 2021 | |
| Cash flows — financing activities: | |||
| Issuances of preferred stock | — | — | 2,000 |
| Issuances of long-term debt | 2,498 | 1,498 | 1,250 |
| Repayments/repurchases of debt | (33) | (251) | (381) |
| Borrowings under Term Loan A | — | — | 1,250 |
| Repayment under Term Loan A | — | — | (1,250) |
| Proceeds from forward capacity agreement | — | — | 500 |
| Net borrowings/(repayments) under accounts receivable financing | (425) | 425 | (300) |
| Borrowings under Revolving Credit Facility | 100 | 1,750 | 1,450 |
| Repayments under Revolving Credit Facility | (350) | (1,500) | (1,450) |
| Borrowings under Commodity-Linked Facility | — | 3,150 | — |
| Repayments under Commodity-Linked Facility | (400) | (2,750) | — |
| Debt issuance costs | (59) | (31) | (13) |
| Stock repurchases | (1,245) | (1,949) | (471) |
| Dividends paid to common stockholders | (313) | (302) | (290) |
| Dividends paid to preferred stockholders | (150) | (151) | — |
| Other, net | 83 | 31 | (21) |
| Cash provided by (used in) financing activities | (294) | (80) | 2,274 |
| Net change in cash, cash equivalents and restricted cash | 3,014 | (834) | 915 |
| Cash, cash equivalents and restricted cash — beginning balance | 525 | 1,359 | 444 |
| Cash, cash equivalents and restricted cash — ending balance | $3,539 | $525 | $1,359 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.